I see no point in selling. Here’s my prediction of what will happen …
PH, LC and BG at the Q&A session seemed genuinely surprised by the share price because “4 out of 7 people have been cured”.
PH will secure funding to see us if not through the full registrational trial, or at least most of the way, and yes, obviously, this will come with massive dilution.
If PH does secure the funding, the shorting will dry up as a pathway forward now exists, and the share price should steadily increase as the registrational trial progresses, as long as there’s no major bad news or set backs. Another point raised in the Q&A - there’s been no real failures and they seemed quite confident in Azercell when asked if they would sell it, the answer was a very firm “NO!”.
Hand-in-hand with the Azer cell progression, MAST and OASIS will continue to crawl through the cohorts, with news dropping irregularly.
I don’t want to quote Lesley, but I now see no other course but to “watch this space”, and we’ll see if my prediction comes true.
IMU Price at posting:
2.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)